Novasure treatment for one case of abnormal uterine bleeding with active systemic lupus erythematosus

Abnormal uterine bleeding (AUB), especially in the menopausal transition period, is showing a tendency of rising in recent years, and after treatment, high recurrence rate for the treatment of hormone treatment, the endometrial resection and uterine resection. But for patients with severe systemic disease with AUB, it may get worse with the conventional treatment. Novasure provides us with an effective measure for the treatment of AUB with active systemic lupus erythematosus (SLE).